KDL DermPath Updates

DermPath Update is a publication of KDL Pathology, published quarterly or more often as warranted to keep clinicians informed. Topics covered include the latest discoveries or improvements in dermatopathology diagnostics to continued improvements and additions in KDL laboratory services.
Please contact clientservices to be put on our mailing list.

KDL DermPath Updates (pdf) :

Archived KDL DermPath  Updates:

News and Events

Cancer survivors may be at higher risk of developing Melanoma. Read report

FDA approves Erivedge, the first drug to treat advanced basal cell carcinoma. Story

Diagnostic Update

KDL now providing FDA-approved BRAF testing for all metastatic melanomas. More

Contact Us

800.772.0951
865.584.1933
clientservices@kdlpathology.com
facebook icon

Stay Connected

Receive the DermPath Update or hear the latest news from KDL Pathology.